Welcome to our dedicated page for Plexus SEC filings (Ticker: PLXS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Plexus Corp (NASDAQ: PLXS) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Plexus files periodic and current reports as a Wisconsin corporation with Commission File Number 001-14423.
Among the key documents available are current reports on Form 8-K, which Plexus uses to furnish press releases announcing quarterly and annual financial results. These filings typically include information on revenue, operating margin, earnings per share, non-GAAP performance measures, return on invested capital, free cash flow and other financial metrics, as well as commentary on business conditions and program wins.
Through this page, users can track how Plexus reports its results for fiscal quarters and years, including references to its geographic segments in the Americas, Asia-Pacific and Europe, Middle East and Africa regions, and its focus on Aerospace/Defense, Healthcare/Life Sciences and Industrial market sectors. Filings also confirm corporate details such as state of incorporation and principal corporate location.
Stock Titan enhances these filings with AI-powered summaries that highlight the most important points from lengthy documents, helping readers quickly understand the implications of each report. Real-time updates from the SEC’s EDGAR system, along with structured access to forms such as 8-K and other periodic reports, make it easier to review Plexus’ regulatory history and monitor ongoing disclosures related to PLXS.
A shareholder of PLXS filed a Rule 144 notice to sell 1,399 shares of common stock through Morgan Stanley Smith Barney LLC on 02/12/2026 on the NASDAQ, with an aggregate market value of $288,183.51 and 26,786,466 shares outstanding.
The shares to be sold were acquired as restricted stock from the issuer, including 676 shares acquired on 01/30/2026 and additional blocks of 165 and 558 shares acquired on 01/31/2025, all listed as fully paid in cash-equivalent terms.
Wuamett Jennifer reported acquisition or exercise transactions in this Form 4 filing.
Plexus Corp. director Jennifer Wuamett received a grant of 1,008 restricted stock units on February 9, 2026. Each unit represents a contingent right to one share of Plexus common stock and was issued under the Plexus Corp. 2024 Omnibus Incentive Plan.
The restricted stock units vest on February 9, 2027, meaning the director receives the underlying shares if vesting conditions are satisfied. After this award, she directly holds 1,008 restricted stock units and 3,349 shares of Plexus common stock.
SCHROCK MICHAEL V reported acquisition or exercise transactions in this Form 4 filing.
Plexus Corp director Michael V. Schrock received a grant of 1,008 Restricted Stock Units (RSUs) on February 9, 2026 under the Plexus Corp 2024 Omnibus Incentive Plan. Each RSU represents a right to one share of common stock and will vest on February 9, 2027.
Following this award, Schrock directly holds 44,329 shares of Plexus common stock and 1,008 RSUs, giving him both current ownership and a contingent future interest tied to the company’s equity.
ROOKE PAUL A reported acquisition or exercise transactions in this Form 4 filing.
Plexus Corp director Paul A. Rooke received a grant of 1,008 Restricted Stock Units on February 9, 2026 under the Plexus Corp. 2024 Omnibus Incentive Plan. Each unit represents a contingent right to receive one share of Plexus common stock and will vest on February 9, 2027.
After this award, Rooke directly beneficially owned 15,991 shares of Plexus Corp common stock, according to the filing.
Rapp Karen Marie reported acquisition or exercise transactions in this Form 4 filing.
Plexus Corp director Karen Rapp reported an equity award on Form 4. On February 9, 2026, she received a grant of 1,008 restricted stock units under the Plexus Corp 2024 Omnibus Incentive Plan. Each unit represents a contingent right to one share of Plexus common stock and vests on February 9, 2027.
Following this award, she directly owned 1,008 restricted stock units and 9,035 shares of Plexus Corp common stock, as reported in the filing.
Quadracci J Joel reported acquisition or exercise transactions in this Form 4 filing.
Plexus Corp director J. Joel Quadracci received a grant of 1,008 restricted stock units on February 9, 2026 under the Plexus Corp 2024 Omnibus Incentive Plan. Each unit represents a contingent right to one share of Plexus common stock and vests on February 9, 2027.
After this grant, Quadracci directly beneficially owns 7,478 shares of Plexus Corp common stock, plus the 1,008 restricted stock units reported in the derivative securities table.
MARTINEZ RANDY J reported acquisition or exercise transactions in this Form 4 filing.
Plexus Corp. director Randy J. Martinez received an equity award in the form of restricted stock units. On February 9, 2026, he was granted 1,008 restricted stock units under the Plexus Corp. 2024 Omnibus Incentive Plan, each representing a contingent right to receive one share of Plexus common stock.
The restricted stock units vest on February 9, 2027, subject to plan terms. Following this grant, Martinez held 1,008 restricted stock units directly and 6,201 shares of Plexus Corp. common stock in direct ownership.
Jueckstock Rainer reported acquisition or exercise transactions in this Form 4 filing.
Plexus Corp. director Rainer Jueckstock received a grant of 1,008 Restricted Stock Units on February 9, 2026 under the Plexus Corp. 2024 Omnibus Incentive Plan. Each unit represents a contingent right to receive one share of Plexus common stock and will vest on February 9, 2027.
After this grant, Jueckstock is reported as directly holding 29,740 shares of Plexus common stock, along with the 1,008 Restricted Stock Units, giving him both current share ownership and a future stock-based award tied to continued service or vesting conditions.
Plexus Corp director Joann M. Eisenhart received a grant of 1,008 Restricted Stock Units on February 9, 2026 under the Plexus Corp. 2024 Omnibus Incentive Plan. Each unit represents a contingent right to one share of common stock and vests on February 9, 2027.
Following this grant, she directly beneficially owned 1,008 Restricted Stock Units and 21,705 shares of Plexus Corp common stock. The grant was made at no stated exercise price and qualifies under Rule 16b-3.
Zycinski Frank reported acquisition or exercise transactions in this Form 4 filing.
Plexus Corp. regional president for EMEA Frank Zycinski received new equity awards in the form of restricted and performance-based stock units. On February 9, 2026, he was granted 900 Restricted Stock Units and 1,270 Performance Stock Units under the Plexus Corp. 2024 Omnibus Incentive Plan.
Each unit represents a contingent right to one share of Plexus common stock. The RSUs vest on February 9, 2029. The PSUs depend on performance: 370 PSUs are tied to relative total shareholder return versus the S&P 400 Index, and the remainder depend on economic return over a three-year period, with potential payouts above target if goals are exceeded. Following these awards, he directly owns 1,399 common shares.